Australis Capital Inc. (AUSA.CN)

0.0750 0.0000 (0.00%) At close: 03:52PM EDT

Australis Capital Inc.

376 East Warm Springs Road
Suite 190
Las Vegas, NV 89119
United States
800 898 0648
https://www.ausa-corp.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Terry Booth	CEO & Director	10.38k	N/A	1965
Mr. Jon Paul	Chief Financial Officer	43.08k	N/A	N/A
Dr. Duke Fu M.B.A., Pharm.D.	COO & Director	96.23k	N/A	N/A
Dr. Jason Ronald Bradley Dyck Ph.D.	Chief Science Officer, Chairman of Scientific Advisory Board & Director	35k	N/A	1969
Mr. Brent Edwin Reuter	Sr. VP of Investor Relations & Strategy	N/A	N/A	1967
Mr. Paul E. Larsen	Gen. Counsel	N/A	N/A	N/A
Mr. Marc Lakmaaker	Sr. VP of Communications & Capital Markets	N/A	N/A	N/A
Mr. Fausto Aceituno Aceituno	Chief Marketing Officer	N/A	N/A	N/A
Ms. Leah S. Bailey	Chief Bus. Devel. Officer	N/A	N/A	1956
Thomas Larssen	Pres of ALPS	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Australis Capital Inc. operates as a cannabis company. It undertakes cannabis, as well as horticulture projects in the United States, Canada, Denmark Finland, Iceland, Germany, the Netherlands, Bahrein, the United Arab Emirates, Southeast Asia, and Australia, as well as other jurisdictions. The company is based in Las Vegas, Nevada.

Corporate Governance

Australis Capital Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.